Bremer Trust National Association decreased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,860 shares of the medical research company’s stock after selling 588 shares during the quarter. Bremer Trust National Association’s holdings in Thermo Fisher Scientific were worth $1,302,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Bank of Nova Scotia Trust Co. acquired a new stake in Thermo Fisher Scientific during the third quarter worth $106,000. Shine Investment Advisory Services Inc. acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at $113,000. Chicago Partners Investment Group LLC acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at $108,000. Ropes Wealth Advisors LLC grew its stake in shares of Thermo Fisher Scientific by 15.8% in the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after buying an additional 97 shares in the last quarter. Finally, Atlantic Trust LLC acquired a new stake in shares of Thermo Fisher Scientific in the second quarter valued at $138,000. 86.22% of the stock is owned by institutional investors.
In related news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now directly owns 302,577 shares of the company’s stock, valued at approximately $58,016,113.98. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.49% of the company’s stock.
A number of equities research analysts have recently weighed in on the company. Zacks Investment Research cut Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a research note on Thursday. Deutsche Bank set a $226.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, October 26th. BTIG Research assumed coverage on Thermo Fisher Scientific in a research note on Friday, January 5th. They issued a “buy” rating and a $230.00 price objective for the company. Leerink Swann lifted their price objective on Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a research note on Monday, October 9th. Finally, Evercore ISI assumed coverage on Thermo Fisher Scientific in a research note on Wednesday, January 3rd. They issued an “outperform” rating and a $220.00 price objective for the company. One analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $212.21.
Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $210.17 on Friday. Thermo Fisher Scientific Inc. has a one year low of $140.00 and a one year high of $211.54. The company has a market capitalization of $83,671.70, a price-to-earnings ratio of 22.93, a P/E/G ratio of 1.70 and a beta of 1.06. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The firm had revenue of $5.12 billion during the quarter, compared to analysts’ expectations of $5.03 billion. During the same period in the previous year, the firm posted $2.03 EPS. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% on a year-over-year basis. analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $0.60 annualized dividend and a yield of 0.29%. Thermo Fisher Scientific’s payout ratio is 10.19%.
TRADEMARK VIOLATION NOTICE: This story was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://ledgergazette.com/2018/01/13/thermo-fisher-scientific-inc-tmo-holdings-cut-by-bremer-trust-national-association.html.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.